Brain, Vol. 125, No. 3, 575-583,
March 2002
© 2002 Guarantors of Brain
Clinical predictive factors of subthalamic stimulation in Parkinsons disease
1 Centre dInvestigation Clinique and INSERM U 289 2 Service de Biostatistique, 3 INSERM EPI 07, 4 Service dExplorations Fonctionnelles Neurologiques, 5 Service de Neuroradiologie and 6 Service de Neurochirurgie, Hôpital de la Salpêtrière, Paris, France
Correspondence to: Dr Y. Agid, Centre dInvestigation Clinique, Hôpital de la Salpêtrière, 47 boulevard de lHôpital, 75013 Paris, France E-mail: agid{at}ccr.jussieu.fr
High-frequency stimulation of the subthalamic nucleus (STN) constitutes one of the most effective treatments for advanced forms of Parkinsons disease. The cost and potential risks of this procedure encourage the determination of clinical characteristics of patients that will have the best postoperative outcome. Forty-one Parkinsons disease patients underwent surgery for bilateral STN stimulation. The selection criteria were severe parkinsonian motor disability, clear response of symptoms to levodopa, occurrence of disabling levodopa-related motor complications and the absence of dementia and significant abnormalities on brain MRI. Clinical evaluation was performed 1 month before and 6 months after surgery. The improvement in the activities of daily living subscale of the Unified Parkinsons Disease Rating Scale, Part II (UPDRS II) and parkinsonian motor disability (UPDRS III) was greater when the preoperative scores for activities of daily living and parkinsonian motor disability, in particular axial symptoms, such as gait disorders and postural instability assessed at the time of maximal clinical improvement (on drug), were lower. Age and disease duration were not predictive, but parkinsonian motor disability tended to be more improved in patients with younger age and shorter disease duration. The severity of levodopa-related motor complications was not a predictive factor. The outcome of STN stimulation was excellent in levodopa-responsive forms of Parkinsons disease, i.e. in patients with selective brain dopaminergic lesions, and moderate in patients with axial motor symptoms and cognitive impairment known to be less responsive or unresponsive to levodopa treatment, i.e. when brain non-dopaminergic lesions develop in addition to the degeneration of the nigrostriatal dopaminergic system. The results are consistent with the classical inclusion criteria for STN stimulation, but imply that the decision to operate on the oldest patients and/or patients with gait and postural disorders, who are poorly responsive to levodopa, should be weighed carefully.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
D. Dormont, D. Seidenwurm, D. Galanaud, P. Cornu, J. Yelnik, and E. Bardinet Neuroimaging and Deep Brain Stimulation AJNR Am. J. Neuroradiol., January 1, 2010; 31(1): 15 - 23. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Le Jeune, D. Drapier, A. Bourguignon, J. Peron, H. Mesbah, S. Drapier, P. Sauleau, C. Haegelen, D. Travers, E. Garin, et al. Subthalamic nucleus stimulation in Parkinson disease induces apathy: A PET study Neurology, November 24, 2009; 73(21): 1746 - 1751. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.J. Groiss, L. Wojtecki, M. Sudmeyer, and A. Schnitzler Review: Deep brain stimulation in Parkinson's disease Therapeutic Advances in Neurological Disorders, November 1, 2009; 2(6): 379 - 391. [Abstract] [PDF] |
||||
![]() |
M. J. Lehmkuhle, S. S. Bhangoo, and D. R. Kipke The Electrocorticogram Signal Can Be Modulated With Deep Brain Stimulation of the Subthalamic Nucleus in the Hemiparkinsonian Rat J Neurophysiol, September 1, 2009; 102(3): 1811 - 1820. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. C. M. Poon and M. G. Irwin Anaesthesia for deep brain stimulation and in patients with implanted neurostimulator devices Br. J. Anaesth., August 1, 2009; 103(2): 152 - 165. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Chastan, G. W. M. Westby, J. Yelnik, E. Bardinet, M. C. Do, Y. Agid, and M. L. Welter Effects of nigral stimulation on locomotion and postural stability in patients with Parkinson's disease Brain, January 1, 2009; 132(1): 172 - 184. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. A. Kuhn, F. Kempf, C. Brucke, L. Gaynor Doyle, I. Martinez-Torres, A. Pogosyan, T. Trottenberg, A. Kupsch, G.-H. Schneider, M. I. Hariz, et al. High-Frequency Stimulation of the Subthalamic Nucleus Suppresses Oscillatory {beta} Activity in Patients with Parkinson's Disease in Parallel with Improvement in Motor Performance J. Neurosci., June 11, 2008; 28(24): 6165 - 6173. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Le Jeune, J. Peron, I. Biseul, S. Fournier, P. Sauleau, S. Drapier, C. Haegelen, D. Drapier, B. Millet, E. Garin, et al. Subthalamic nucleus stimulation affects orbitofrontal cortex in facial emotion recognition: a pet study Brain, June 1, 2008; 131(6): 1599 - 1608. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Anheim, A. Batir, V. Fraix, M. Silem, S. Chabardes, E. Seigneuret, P. Krack, A.-L. Benabid, and P. Pollak Improvement in Parkinson Disease by Subthalamic Nucleus Stimulation Based on Electrode Placement: Effects of Reimplantation Arch Neurol, May 1, 2008; 65(5): 612 - 616. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. U. Ferraye, B. Debu, V. Fraix, J. Xie-Brustolin, S. Chabardes, P. Krack, A-L Benabid, and P. Pollak Effects of subthalamic nucleus stimulation and levodopa on freezing of gait in Parkinson disease Neurology, April 15, 2008; 70(16_Part_2): 1431 - 1437. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. E. Ahlskog Beating a dead horse: Dopamine and Parkinson disease Neurology, October 23, 2007; 69(17): 1701 - 1711. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. -P. Derost, L. Ouchchane, D. Morand, M. Ulla, P. -M. Llorca, M. Barget, B. Debilly, J. -J. Lemaire, and F. Durif Is DBS-STN appropriate to treat severe Parkinson disease in an elderly population? Neurology, April 24, 2007; 68(17): 1345 - 1355. [Abstract] [Full Text] [PDF] |
||||
![]() |
W.M.M. Schupbach, D. Maltete, J. L. Houeto, S. T. du Montcel, L. Mallet, M. L. Welter, M. Gargiulo, C. Behar, A. M. Bonnet, V. Czernecki, et al. Neurosurgery at an earlier stage of Parkinson disease: A randomized, controlled trial Neurology, January 23, 2007; 68(4): 267 - 271. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-L. Houeto, L. Mallet, V. Mesnage, S. Tezenas du Montcel, C. Behar, M. Gargiulo, F. Torny, A. Pelissolo, M.-L. Welter, and Y. Agid Subthalamic Stimulation in Parkinson Disease: Behavior and Social Adaptation. Arch Neurol, August 1, 2006; 63(8): 1090 - 1095. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Schupbach, M. Gargiulo, M. L. Welter, L. Mallet, C. Behar, J. L. Houeto, D. Maltete, V. Mesnage, and Y. Agid Neurosurgery in Parkinson disease: A distressed mind in a repaired body? Neurology, June 27, 2006; 66(12): 1811 - 1816. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Pahwa, S. A. Factor, K. E. Lyons, W. G. Ondo, G. Gronseth, H. Bronte-Stewart, M. Hallett, J. Miyasaki, J. Stevens, and W. J. Weiner Practice Parameter: treatment of Parkinson disease with motor fluctuations and dyskinesia (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology, April 11, 2006; 66(7): 983 - 995. [Abstract] [Full Text] [PDF] |
||||
![]() |
V Fraix, J-L Houeto, C Lagrange, C Le Pen, P Krystkowiak, D Guehl, C Ardouin, M-L Welter, F Maurel, L Defebvre, et al. Clinical and economic results of bilateral subthalamic nucleus stimulation in Parkinson's disease J. Neurol. Neurosurg. Psychiatry, April 1, 2006; 77(4): 443 - 449. [Abstract] [Full Text] [PDF] |
||||
![]() |
W M M Schupbach, N Chastan, M L Welter, J L Houeto, V Mesnage, A M Bonnet, V Czernecki, D Maltete, A Hartmann, L Mallet, et al. Stimulation of the subthalamic nucleus in Parkinson's disease: a 5 year follow up J. Neurol. Neurosurg. Psychiatry, December 1, 2005; 76(12): 1640 - 1644. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. C. Rodriguez-Oroz, J. A. Obeso, A. E. Lang, J.-L. Houeto, P. Pollak, S. Rehncrona, J. Kulisevsky, A. Albanese, J. Volkmann, M. I. Hariz, et al. Bilateral deep brain stimulation in Parkinson's disease: a multicentre study with 4 years follow-up Brain, October 1, 2005; 128(10): 2240 - 2249. [Abstract] [Full Text] [PDF] |
||||
![]() |
M Capecci, R A Ricciuti, D Burini, V G Bombace, L Provinciali, M Iacoangeli, M Scerrati, and M G Ceravolo Functional improvement after subthalamic stimulation in Parkinson's disease: a non-equivalent controlled study with 12-24 month follow up J. Neurol. Neurosurg. Psychiatry, June 1, 2005; 76(6): 769 - 774. [Abstract] [Full Text] [PDF] |
||||
![]() |
V Czernecki, B Pillon, J L Houeto, M L Welter, V Mesnage, Y Agid, and B Dubois Does bilateral stimulation of the subthalamic nucleus aggravate apathy in Parkinson's disease? J. Neurol. Neurosurg. Psychiatry, June 1, 2005; 76(6): 775 - 779. [Abstract] [Full Text] [PDF] |
||||
![]() |
S Colnat-Coulbois, G C Gauchard, L Maillard, G Barroche, H Vespignani, J Auque, and P. P Perrin Bilateral subthalamic nucleus stimulation improves balance control in Parkinson's disease J. Neurol. Neurosurg. Psychiatry, June 1, 2005; 76(6): 780 - 787. [Abstract] [Full Text] [PDF] |
||||
![]() |
M Samuel and V Voon Beyond the holy grail of motor symptoms: deep brain stimulation for Parkinson's disease J. Neurol. Neurosurg. Psychiatry, June 1, 2005; 76(6): 759 - 760. [Full Text] [PDF] |
||||
![]() |
F. Bonneville, M. L. Welter, C. Elie, S. T. du Montcel, D. Hasboun, C. Menuel, J. L. Houeto, A. M. Bonnet, V. Mesnage, B. Pidoux, et al. Parkinson disease, brain volumes, and subthalamic nucleus stimulation Neurology, May 10, 2005; 64(9): 1598 - 1604. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. C. Anderson, K. J. Burchiel, P. Hogarth, J. Favre, and J. P. Hammerstad Pallidal vs Subthalamic Nucleus Deep Brain Stimulation in Parkinson Disease Arch Neurol, April 1, 2005; 62(4): 554 - 560. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Russmann, J. Ghika, J.-G. Villemure, B. Robert, J. Bogousslavsky, P. R. Burkhard, and F. J.G. Vingerhoets Subthalamic nucleus deep brain stimulation in Parkinson disease patients over age 70 years Neurology, November 23, 2004; 63(10): 1952 - 1954. [Abstract] [Full Text] [PDF] |
||||
![]() |
B Ford, L Winfield, S L Pullman, S J Frucht, Y Du, P Greene, J H Cheringal, Q Yu, L J Cote, S Fahn, et al. Subthalamic nucleus stimulation in advanced Parkinson's disease: blinded assessments at one year follow up J. Neurol. Neurosurg. Psychiatry, September 1, 2004; 75(9): 1255 - 1259. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Maltete, S. Navarro, M.-L. Welter, S. Roche, A.-M. Bonnet, J.-L. Houeto, V. Mesnage, B. Pidoux, D. Dormont, P. Cornu, et al. Subthalamic Stimulation in Parkinson Disease: With or Without Anesthesia? Arch Neurol, March 1, 2004; 61(3): 390 - 392. [Abstract] [Full Text] [PDF] |
||||
![]() |
K Dujardin, S Blairy, L Defebvre, P Krystkowiak, U Hess, S Blond, and A Destee Subthalamic nucleus stimulation induces deficits in decoding emotional facial expressions in Parkinson's disease J. Neurol. Neurosurg. Psychiatry, February 1, 2004; 75(2): 202 - 208. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Devos, E. Labyt, P. Derambure, J. L. Bourriez, F. Cassim, N. Reyns, S. Blond, J. D. Guieu, A. Destee, and L. Defebvre Subthalamic nucleus stimulation modulates motor cortex oscillatory activity in Parkinson's disease Brain, February 1, 2004; 127(2): 408 - 419. [Abstract] [Full Text] [PDF] |
||||
![]() |
G Linazasoro, J L Houeto, V Mesnage, L Mallet, M L Welter, D Dormont, B Pidoux, P Cornu, and Y Agid Subthalamic deep brain stimulation for advanced Parkinson's disease: all that glitters is not gold J. Neurol. Neurosurg. Psychiatry, June 1, 2003; 74(6): 827 - 827. [Full Text] [PDF] |
||||
![]() |
J.-L. Houeto, M.-L. Welter, P.-B. Bejjani, S. T. du Montcel, A.-M. Bonnet, V. Mesnage, S. Navarro, B. Pidoux, D. Dormont, P. Cornu, et al. Subthalamic Stimulation in Parkinson Disease: Intraoperative Predictive Factors Arch Neurol, May 1, 2003; 60(5): 690 - 694. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. B. Montgomery Jr., P.D. Charles, N. Van Blercom, P. Krack, S.L. Lee, J. Xie, G. Besson, A.L. Benabid, and P. Pollak Predictors of effective bilateral subthalamic nucleus stimulation for PD Neurology, March 11, 2003; 60(5): 886 - 887. [Full Text] [PDF] |
||||
![]() |
V Mesnage, J-L Houeto, M-L Welter, Y Agid, B Pidoux, D Dormont, and P Cornu Parkinson's disease: neurosurgery at an earlier stage? J. Neurol. Neurosurg. Psychiatry, December 1, 2002; 73(6): 778 - 778. [Full Text] [PDF] |
||||
![]() |
R. Pahwa, S. A. Factor, K. E. Lyons, W. G. Ondo, G. Gronseth, H. Bronte-Stewart, M. Hallett, J. Miyasaki, J. Stevens, and W. J. Weiner Practice Parameter: treatment of Parkinson disease with motor fluctuations and dyskinesia (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology, April 11, 2006; 66(7): 983 - 995. [Abstract] [Full Text] [PDF] |
||||








